Ex-CEO of Intel Invests $1.5m Into Medical Research [Medicine]

Being a Parkinson’s disease sufferer, and previously having prostate cancer, Andrew Grove knows all to well the ins and outs of hospital life. That’s partly why the ex-CEO and chairman of Intel has pumped money into “translational medicine” research. More »










HealthMedical researchConditions and DiseasesParkinson’s diseaseCancer